1. Weinstock M, Stewart HC, Butterworth KR. Lenticular effect in mice of some morphine-like drugs. Nature 182: 1519-1520, 1958.
2. Weinstock M, Stewart HC. Occurrence in rodents of reversible drug-induced opacities of the lens. Br J Ophthalmol 45: 408-414, 1961.
3. Weinstock M. Similarity between receptors responsible for the production of analgesia and lenticular opacity in mice. Br J Pharmacol 17: 433- 441, 1961.
4. Weinstock M, Stewart HC, Butterworth KR. The action of drugs on the formation of transient lens opacities. Exp Eye Res 2: 28-32, 1963.
5. Cox BM, Weinstock M. Quantitative studies of the antagonism by nalorphine of some actions of morphine-like analgesic drugs. Br J Pharmacol 22: 289-300, 1964.
6. Cox BM, Weinstock M. The effect of analgesic drugs on the release of acetylcholine from electrically stimulated guinea pig ileum. Br J Pharmacol 27: 81-92, 1966.
7. Weinstock M, Scott JD. Effects of various agents on drug induced opacities of the lens. Exp Eye Res 6: 368-375, 1967.
8. Weinstock M. The role of the sympathetic nervous system in mediating the action of analgesic drugs on the lens. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 259(2): 201 -202, 1968.
9. Weinstock M, Marshall SA. The influence of the sympathetic nervous system on the action of drugs on the lens. J Pharmacol Exptl Ther 166: 8-13, 1969.
10. Weinstock M, Marshall SA. Factors influencing the incidence of reversible lens opacities in solitary and aggregated mice. J Pharmacol Exptl Ther 170: 168-172, 1969.
11. Marshall I, Weinstock M. A quantitative method for the assessment of physical dependence on narcotic analgesics in mice. Br J Pharmacol 37(2): 505P-506P, 1969.
12. Starr MS, Weinstock M. Studies in pollen allergy I. A method for estimating histamine release from sensitised leucocytes in the presence of serum. Int Arch Allergy 37: 239-247, 1970.
13. Weinstock M, Starr MS. Studies in pollen allergy II. Comparison of leucocyte sensitivity and levels of blocking antibody in hay fever subjects administered Allpyral or Pollaccine. Int Arch Allergy 37: 385-392, 1970.
14. Starr MS, Weinstock M. Studies in pollen allergy III. Relationship between blocking antibody levels and symptomatic relief of hay fever after treatment with Allpyral. Int Arch Allergy 38: 514-523, 1970.
15. Marshal M, Weinstock M. Quantitative method for assessing one symptom of the withdrawal syndrome in mice after chronic morphine administration. Nature 234: 223-224, 1971.
16. Eliash S, Weinstock M. Role of adrenergic neurone blockade in the hypotensive action of propranolol. Br J Pharmacol 43: 287-294, 1971.
17. Starr MS, Weinstock M. Relationship between blocking antibody titres and symptomatic relief in hay-fever subjects treated with allpyral. Int Arch Allergy Appl Immunol 41(1): 157-159, 1971.
18. Eliash S, Weinstock M. Factors influencing the adrenergic neurone blocking action of propranolol. Br J Pharmacol. 45: 630-634, 1972.
19. Weinstock M, Speiser Z. The effect of dl-propranolol, d-propranolol and practolol on the hyperactivity induced in rats by prolonged isolation. Psychopharmacol 30: 241-250, 1973.
20. Weinstock M, Speiser Z. Modification by propranolol and related compounds of motor activity and stereotype behaviour induced in the rat by amphetamine. Eur J Pharmacol 25: 29-35, 1974.
21. Schechter Y, Weinstock M. Beta-adrenoceptor blocking agents and responses to adrenaline and 5-hydroxytryptamine in rat isolated stomach and uterus. Br J Pharmacol 52: 283-287, 1974.
22. Weinstock M, Schechter Y, Erez M, Shtacher G. Changes in beta-adrenoceptor-blocking activity produced by chemical modifications in the practolol molecule. Eur J Pharmacol 26: 191-197, 1974.
23. Shoham S, Weinstock M. The role of supersensitivity to acetylcholine in the production of tolerance to morphine in stimulated guinea pig ileum. Br J Pharmacol 52: 597-603, 1974.
24. Speiser Z, Weinstock M. Supersensitivity to isoprenaline induced by rats by prolonged isolation. Br J Pharmacol 52: 605-608, 1974.
25. Weinstock M, Shoham S. Seasonal variation in sensitivity of guinea pig tissues to agonists. Nature 251: 427-428, 1974.
26. Weinstock M, Shoham S. Can pharmacological denervation supersensitivity explain tolerance to opiates? Proc. Nat. Acad. Sci. 623-634, 1975.
27. Weinstock M, Shechter Y. Antagonism by propranolol of the ganglion stimulant action of 5-hydroxytryptamine. Eur J Pharmacol 32: 293-301, 1975.
28. Erez M, Weinstock M, Cohen S, Shtacher G. Potential probe for isolation of the beta-adrenoceptor: Chloropractolol. Nature 255: 635-636, 1975.
29. Speiser Z, Weinstock M. Reduction by propranolol of raised output of MHPG in hyperactive rats. Pharmacol Biochem Behav 4: 531-534, 1976.
30. Fisher A, Weinstock M, Gitter S, Cohen S. A new probe for heterogeneity in muscarinic receptors: 2-methylspiro (1,3-dioxolane-4, 3w) quinuclidine. Eur J Pharmacol 38: 131-140, 1976.
31. Fisher A, Grunfeld Y, Weinstock M, Gitter S, Cohen S. A study of muscarinic receptor heterogeneity with weak antagonists. Eur J Pharmacol 37: 329-338, 1976.
32. Weinstock M, Cohen D. Tricyclic antidepressant drugs as antagonists of muscarinic receptors in sympathetic ganglia. Eur J Pharmacol 40: 321-328, 1976.
33. Weinstock M. The presynaptic inhibitory effect of beta adrenoceptor antagonists on noradrenergic neurones. Minireview. Life Sci 19: 1453-1466, 1976.
34. Fisher A, Weinstock M, Eliash S, Gitter S, Cohen S. Allosteric effects in the cat superior cervical ganglion in situ. Eur J Pharmacol 42: 11-20, 1977.
35. Shoham-Moshonov SR, Weinstock M. Nature of seasonal variation in development of acute tolerance to morphine. Eur J Pharmacol 43: 153-161, 1977.
36. Weinstock M, Shoham-Moshonov SR, Teitelbaum D, Arnon R. Inactivation of neurogenic 5-hydroxytryptamine receptors in guinea pigs with experimental allergic encephalomyelitis (EAE) induced paralysis. Brain Res 125: 192-195, 1977.
37. Weinstock M, Weiss C, Gitter S. Blockade of 5-hydroxytryptamine receptors in the central nervous system by β- adrenoceptor antagonists. Neuropharmacol 16: 273-276, 1977.
38. Zatz M, Weinstock M. Electrical field stimulation releases norepinephrine and cyclic GMP from the rat pineal gland. Life Sci 22: 767-276, 1978.
39. Weinstock M, Thoa NB, Kopin IJ. -adrenoceptors modulate noradrenaline release from axonal sprouts in cultured rat superior cervical ganglia. Eur J Pharmacol 47: 297-302, 1978.
40. Weinstock M, Zavadil AP, Rosin AJ, Chieuh CC, Kopin IJ. The role of peripheral catechol- amines in oxotremorine tremor in the rat and its antagonism by beta-adrenoceptor blocking drugs. J Pharmacol Exptl Ther 206: 91-96, 1978.
41. Weinstock M, Speiser Z, Ashkenazi R. Changes in brain catecholamine turnover and receptor sensitivity induced by social deprivation in rats. Psychopharmacol 56: 205-209, 1978.
42. Erez MJ, Shtacher G, Weinstock M. Cardioselectivity as a function of molecular structure in (β-adrenoceptor blocking agents of the l-(para-substituted aryloxy)- (isopropylamino) propanol type. J Med Chem 21: 982-984, 1978.
43. Weinstock M, Weiss C. Effects of procaine and extracellular calcium concentration on response of rat stomach fundus to acetylcholine and 5-hydroxytryptamine. Br J Pharmacol 65: 593-599, 1979.
44. Weinstock M, Zavadil III AP, Chieuh CC, Kopin IJ. The effect of oxotremorine on blood pressure and plasma catecholamines in conscious and anesthetized rats. Life Sci 24: 301-310, 1979.
45. Weinstock M, Zavadil III AP, Kopin IJ. Differential effects of d and l-propranolol on dopamine turnover stimulated by oxotremorine in striatal and mesolimbic areas of rat brain. Eur J Pharmacol 59: 187-193, 1979.
46. Weinstock M, Zavadil III AP, Kopin IJ. Peripheral catecholamines mediate certain responses to central cholinergic receptor stimulation by oxotremorine. Monogr Neural Sci 7: 138-145, 1980.
47. Weinstock M, Weiss C. Antagonism by propranolol of isolation-induced aggression in mice: correlation with 5-hydroxytryptamine receptor blockade. Neuropharmacol 19: 653-656, 1980.
48. Manoach M, Netz H, Erez M, Weinstock M. Ventricular self-defibrillation in mammals: Age and drug dependence. Age Aging 9: 112-116, 1980.
49. Weinstock M, Zavadil III AP, Muth EA, Crowley WR, O'Donohue TL, Jacobowitz DM, Kopin IJ. Evidence that noradrenaline modulates the increase in striatal dopamine metabolism induced by muscarinic receptor stimulation. Eur J Pharmacol 68: 427-437, 1980.
50. Weinstock M, Roll D, Erez E, Bahar M. Physostigmine antagonizes morphine induced respiratory depression but not analgesia in dogs and rabbits. Br J Anaesth 52: 1171-1176, 1980.
51. Weinstock M, Roll D, Zilberman Y. An analysis of the respiratory stimulant effect of physostigmine and neostigmine in the conscious rabbit. Clin Exptl Pharmacol Physiol 8: 151-158, 1981.
52. Weinstock M, Erez E, Roll D. Antagonism of the cardiovascular and respiratory depressant effect of morphine in the conscious rabbit by physostimgine. J Pharmacol Exptl Ther 218: 504-508, 1981.
53. Weinstock M. Activation of central muscarinic receptors causes respiratory stimulation in conscious animals. Br J Pharmacol 74: 587-592, 1981.
54. Weinstock M, Davidson JT, Rosin AJ, Schnieden H. Effect of physostigmine on morphine-induced post-operative pain and somnolence. Brit J Anaesth 54: 429-434, 1982.
55. Segal M, Weinstock M. Differential effect of 5-hydroxytryptamine antagonists on behaviours resulting from activation of different pathways arising from the raphe nuclei. Psychopharmacol 79: 72-78, 1983.
56. Weinstock M, McCarty R. Vasodilator responses to cholinergic and adrenergic stimulants in spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) normotensive rats. Proc Soc Exp Biol Med 172: 194-201, 1983.
57. Blum B, Weinstock M, Israeli J, Motles E, Davidovich Z, Farchi M, Mihiz M. A pharmacological analysis of autonomic pathways mediating myocardial disturbances originating in a lateral hypothalamic area of the cat. Eur J Pharmacol 88: 301-310, 1983.
58. Snir-Mor I, Weinstock M, Bahar M, Davidson JT. Physostigmine antagonizes morphine-induced respiratory depression in human subjects. Anesthesiology 59: 6-9, 1983.
59. Weinstock M, Dalith M, Shohami E. Hypersensitivity of morphine-tolerant rabbits to the respiratory stimulant effect of a cholinergic agonist. J Pharmacol Exptl Therap 226: 232-237, 1983.
60. Weinstock M, Rosin AJ. Relative contributions of vagal and cardiac sympathetic nerves to the reflex bradycardia induced by a pressor stimulus in the conscious rabbit: comparison of "steady state" and "ramp" methods. Clin Exptl Pharmacol Physiol 11: 133-141, 1984.
61. Weinstock M, Schorer-Apelbaum D, Ben Ishay D. Baroreflex sensitivity and susceptibility to systolic hypertension induced by DOCA-salt in the Sabra rat. Am J Physiol 246: H488-H452, 1984.
62. Schorer-Apelbaum D, Weinstock M, Ben Ishay D. Sympathetic component of baroreflex control of heart rate is impaired in hypertension-prone (SBH) Sabra rats. J Hypertension 2: 257-260, 1984.
63. Weinstock M, Schorer-Apelbaum D, Rosin AJ. Endogenous opiates mediate cardiac sympathetic inhibition in response to a pressor stimulus in rabbits. J Hypertension 2: 639-646, 1984.
64. Vatashsky E, Beilin B, Aronson HB, Weinstock M. Oral flunitrazepam in the prevention of local anesthetic-induced convulsions in mice. Can J Anaesth 31: 646-649, 1984.
65. Amitzur G, Manoach M, Weinstock M. The influence of cardiac cholinergic activation on the induction and maintainance of ventricular fibrillation. Basic Res Cardiol 79: 690-697, 1984.
66. Chrubasik J, Meynadier J, Blond S, Scherpereel P, Ackerman E, Weinstock M, Bonoth K, Cramer H, Wunsch E. Somatostatin: A potent analgesic. Lancet II: 1208-1209, 1984.
67. Fride E, Weinstock M. The effects of prenatal exposure to predictable or unpredictable stress on early development in the rat. Dev Psychobiol 17: 651-660, 1984.
68. Fride E, Dan Y, Gavish M, Weinstock M. Prenatal stress impairs maternal behavior in a conflict situation and reduces hippocampal benzodiazepine receptors. Life Sci 36: 2103-2109, 1985.
69. Weinstock M, Schorer-Apelbaum D. Impaired baroreflex sensitivity in the aetiology of salt hypertension in the rabbit. Clin Sci 68: 489-493, 1985.
70. Beilin B, Vatashsky E, Aronson HB, Weinstock M. Naloxone reversal of postoperative apnea in the premature infant. Anesthesiology 63: 317-318, 1985.
71. Ackerman E, Chrubasic J, Weinstock M. Wunsch, E. Effect of intrathecal somatostatin on pain threshold in rats. Pain 2: 41-42, 1985.
72. Beilin B, Vatashsky E, Weinstock M. Physostigmine as an antidote for poisoning by combination of thioridazine and trihexylphenydyl. Brit J Clin Practice 39: 440-441, 1985.
73. Weinstock M, Blotnik S, Segal M. Seasonal variation in the development of stress-induced systolic hypertension in the rat. J Hypertension 3 (suppl. 3): S107-S109, 1985.
74. Rubini E, Gilon C, Levian D, Teitelbaum T, Selinger Z, Weinstock M, Chorev M. Isoteric methylene analogs of the neuropeptide substance P and enkephalins. Peptides, 1985.
75. Weinstock M, Razin M, Chorev M, Tashma Z. Pharmacological activity of novel anticholinesterase agents of potential use in the treatment of Alzheimer's disease. Adv Behav Biol 29: 539-551, 1986.
76. Fride E, Dan Y, Feldon J, Halevy G, Weinstock M. Effects of prenatal stress on vulnerability to stress during development and at adulthood. Physiol Behav 37: 681-687, 1986.
77. Fride E, Soreq H, Weinstock M. Are the effects of gestational stress on motor development and cerebellar cholinesterase activity mediated prenatally? Int J Develop Neurosci 4: 407-413, 1986.
78. Shohami E, Evron S, Weinstock M, Soffer D, Carmon A. A new animal model for action myoclonus. Adv Neurol 43: 545-552, 1986.
79. Vatashsky E, Beilin B, Razin M, Weinstock M. Mechanism of antagonism by physostigmine of acute flunitrazepam intoxication. Anesthesiology 64: 248-252, 1986.
80. Benita S, Friedman D, Weinstock M. Physostigmine emulsion: a new injectable controlled release delivery system. Int J Pharm 30: 47-55, 1986.
81. Benita S, Friedman D, Weinstock, M. Pharmacological evaluation of an injectable prolonged release emulsion of physostigmine in rabbits. J Pharm Pharmacol 38: 653-658, 1986.
82. Benita S, Friedman D, Weinstock M. Evaluation of the reversal of flunitrazepam intoxication by a controlled-release physostigmine emulsion. STP Pharma (20/21): 923-926, 1986.
83. Weinstock M, Weksler-Zangen S, Schorer-Apelbaum D. Genetic factors involved in the determination of baroreceptor heart-rate sensitivity. J Hypertension 4: S290-S292, 1986.
84. Manoach M, Netz H, Varon D, Amitzur G, Weinstock M, Kauli N, Assael M. Factors influencing spontaneous initiation and termination of ventricular fibrillation. Jap Heart J 27: 365-75, 1986.
85. Hovav E, Weinstock M. Temporal factors influencing the development of acute tolerance to opiates. J Pharmacol Exptl Ther 242: 251-256, 1987.
86. Fride E, Weinstock M. Increased interhemispheric coupling of the dopamine systems induced by prenatal stress. Brain Res Bull 18: 457-461, 1987.
87. Melmed RN, Roth D, Weinstock-Rosin M, Edelstein EI. The influence of emotional state on the mobilization of marginal pool leucocytes after insulin-induced hypoglycemia. Ann NY Acad Sci 496: 467-476, 1987.
88. Weinstock M, Korner PI, Head GA, Dorward PK. Differentiation of cardiac baroreflex properties by cuff and drug methods in two rabbit strains. Am J Physiol 255: R654-R664, 1988.
89. Fride E, Weinstock M. Prenatal stress increases anxiety-related behavior and alters cerebral lateralization of dopamine activity. Life Sci 42: 1059-1065, 1988.
90. Weinstock M, Fride E, Hertzberg R. Prenatal stress effects on functional development of the offspring. Review: Progr Brain Res 73: 319-331, 1988.
91. Chorev M, Gilon N, Rubini E, Ackerman E, Levian-Teitelbaum D, Weinstock M. Partially modified retro-inverso enkephalin analogues containing Gly3(NH-CO) PHE4 modification, configurational lability. Coll Czech Chem Commun 53: 2519-2536, 1988.
92. Ben-Ishay D, Devynck MA, Parini A, Dausse JP, Weinstock M, Meyer P. [Hereditary resistance to salt-induced hypertension. What mechanisms?] Néphrologie 9(1):15 -20, 1988 (French).
93. Fride E, Weinstock M. Alterations in behavioral and striatal dopamine asymmetries induced by prenatal stress. Pharmacol Biochem Behav 32: 425-430, 1989.
94. Weinstock M, Weksler-Zangen S. Opioid peptides mediate sympathetic inhibition in response to baroreceptor activation in a distinct genetic strain of rabbit. Clin Exptl Pharmacol Physiol 15: 97-101, 1989.
95. Wakshlak A, Weinstock M. Neonatal handling reverses behavioral abnormalities induced in rats by prenatal stress. Physiol Behav 48: 289-292, 1990.
96. Elmalem E, Chorev M, Weinstock M. Antagonism of morphine induced respiratory depression by novel anticholinesterase agents. Neuropharmacol 30: 1059-1064, 1991.
97. Weinstock M, Borosh M, Kafri O, Kaczmarczyk G. Relationship between baroreflex sensitivity, renin suppression and natriuresis in salt sensitive rabbits. J Hypertension 9: 799-804, 1991.
98. Weksler-Zangen S, Chorev M, Weinstock M. Contrasting influences of central and peripheral opioids on cardiac baroreflex sensitivity in rabbits. J Cardiovasc Pharmacol 20: 688-693, 1992.
99. Weinstock M, Matlina E, Keshet GI, Rosen H, McEwen BS. Prenatal stress selectively alters the reactivity of the hypothalamic-pituitary adrenal system in the female rat. Brain Res 595: 195-200, 1992.
100. Razin M, Borosh M, Weinstock M. Rabbits with a genetic impairment in baroreceptor reflex sensitivity show abnormal renal haemodynamics and proximal tubular sodium reabsorption in response to a saline infusion. J Hypertension 11: 799-804, 1993.
101. Weinstock M, Borosh M. Low baroreflex sensitivity predisposes to salt-sensitive hypertension in the rabbit. Am. J. Physiol. 264: H505-H511, 1993.
102. Weinstock M, Razin M, Chorev M, Enz A. Pharmacological evaluation of phenyl-carbamates as CNS-selective acetylcholinesterase inhibitors. J Neural Transm 43 (suppl.): 219-225, 1994.
103. Keshet GI, Weinstock M. Maternal naltrexone reverses abnormalities induced by prenatal stress in rats. Regulatory Peptides S1: 94-96, 1994.
104. Keshet GI, Weinstock M. Maternal naltrexone prevents morphological and behavioral alterations induced in rats by prenatal stress. Pharmacol Biochem Behav 50: 413-419, 1995.
105. Weinstock M, Gorodetsky M. Comparison of the effects of angiotensin, losartan and enalapril on baroreflex control of heart rate in conscious rabbits. J Cardiovasc Pharmacol 25: 501-507, 1995.
106. Weinstock M. The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: An update. Neurodegeneration 4: 349-356, 1995.
107. Kaczmarczyk G, Koch L, Mohnhaupt R, Vogel T, Weinstock M. Cardiac baroreflex sensitivity and sodium excretion are reduced both by a deficit and an excess of dietary salt in the conscious dog. J Lab Clin Med 125: 120-126, 1995.
108. Weinstock M, Billig H. [Pharmacological strategies for the treatment of Alzheimer's disease]. Gerontology 68: 29-42, 1995 (Hebrew).
109. Friedman L, Rasouly D, Weinstock M, Lazarovici P. Staurosporine, an alkaloid toxin known as protein kinase inhibitor, suppressed phorbol ester effects on Alzheimer precursor protein levels in PC12 cells. Toxicon 33: 305, 1995.
110. Cohen E, Keshet GI, Shavit Y, Weinstock M. Prenatal naltrexone facilitates male sexual behavior in the rat. Pharmacol Biochem Behav 54:183-188, 1996.
111. Weinstock M, Gorodetsky E, Kalman R. Renal denervation prevents sodium retention and hypertension in salt-sensitive rabbits with genetic baroreflex impairment. Clin Sci 90: 287-293, 1996.
112. Poltyrev T, Keshet GI, Kay G, Weinstock M. Role of experimental conditions in determining differences in exploratory behavior of prenatally-stressed rats. Dev Psychobiol 29: 453-462, 1996.
113. Chen Y, Constantini S, Trembovler V, Weinstock M, Shohami E. An experimental model of closed head injury in mice: Pathophysiology, histopathology and cognitive deficits. J Neurotrauma 13: 557-569, 1996.
114. Poltyrev P, Weinstock M. Effect of prenatal stress on opioid component of exploration in different experimental situations. Pharmacol Biochem Behav 58: 387-393, 1997.
115. Weinstock M. Does prenatal stress impair coping and regulation of the hypothalamic-pituitary-adrenal axis? Neurosci Biobehav Revs 21: 1-10, 1997.
116. Weinstock M. Possible role of cholinergic system and disease models. J Neural Transm Suppl 49: 93-102, 1997.
117. Kay G, Tarcic N, Poltyrev T, Weinstock M. Prenatal stress depresses immune function in rats. Physiol Behav 63: 397-402, 1998.
118. Weinstock M. Increase in cerebral blood flow and glucose utilization in the beneficial effect of a cholinesterase inhibitor, ENA713 in Alzheimer's disease. Adv Behav Biol 49: 587-595, 1998.
119. Chen Y, Shohami E, Bass R, Weinstock M. Cerebro-protective effects of ENA713, a novel acetylcholinesterase inhibitor, in closed head injury in the rat. Brain Res 784: 18-24, 1998.
120. Maybaum N, Gorodetsky E, Kalman R, Weinstock M. Role of renal nerves in the hemodynamic and natriuretic response to saline in rabbits with impaired baroreflex sensitivity. Renal Failure 20: 219-229, 1998.
121. Chen Y, Shohami E, Constantini S, Weinstock M. Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed-head injury in the mouse. J Neurotrauma 15: 231-237, 1998.
122. Weinstock M, Razin M, Schorer-Apelbaum D, Men D, McCarty R. Gender differences in sympathoadrenal activity in rats at rest and in response to footshock stress. Int J Dev Neurosci 16: 289-295, 1998.
123. Weinstock M, Poltyrev T, Schorer-Apelbaum D, Men D, McCarty R. Effect of prenatal stress on plasma corticosterone and catecholamines in response to footshock in rats. Physiol Behav 64: 439-444, 1998.
124. Chapman S, Fisher, A, Weinstock M, Brandies R, Shohami E, Michaelson DM. The effects of the acetylcholinesterase inhibitor ENA713 and the M1 agonist AF150(S) on apolipoprotein E deficient mice. J Physiol 92: 299-303, 1998.
125. Maybaum N, Gorodetsky E, Weinstock M. Relationship between arterial baroreflex, cardiopulmonary vagal reflex and renal natriuretic response to saline in conscious rabbits. Clin Sci 95: 693-699, 1998.
126. Huang W, Chen Y, Shohami E, Weinstock M. Neuroprotective effect of rasagiline, a selective MAO-B inhibitor, against closed head injury in the mouse. Eur J Pharmacol 366: 127-135, 1999.
127. Weinstock M. Selectivity of cholinesterase inhibition: Clinical implications for the treatment of Alzheimer’s disease. CNS Drugs (invited review) 12: 307-323, 1999.
128. Finberg JP, Lamensdorf I, Weinstock M, Schwartz M, Youdim MBH. Pharmacology of rasagiline (N-propargyl-1R-aminoindan). Adv Neurol 80: 495-499, 1999.
129. Poltyrev T, Weinstock M. Effect of gestational stress on maternal behavior in response to cage transfer and handling of pups in two strains of rat. Stress 3: 85-95, 1999.
130. Bejar C, Wang RH, Weinstock M. Effect of of rivastigmine on scopolamine-induced memory impairment in rats. Eur J Pharmacol 383: 231-240, 1999.
131. Chapman S, Grauer E, Chen Y, Shohami E, Weinstock M, Michaelson DM. The cognitive and neurochemical effects of the anti-cholinesterase inhibitor ENA 713 on apolipoprotein E-deficient mice. Int J Ger Psychopharmacol 1:171-175, 1999.
132. Wang RH, Bejar C, Weinstock M. Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats. Neuropharmacol 39: 497-506, 2000.
133. Weinstock M, Goren T, Youdim MBH. Development of a novel neuroprotective drug (TV3326) for the treatment of Alzheimer’s disease, with cholinesterase and monoamine oxidase inhibitory activities. (invited review) Drug Dev Res 50: 216-222, 2000.
134. Weinstock M, Bejar C, Wang RH, Poltyrev T, Gross A, Finberg JPM, Youdim MBH. TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer’s disease. J Neural Transm (suppl) 60: 157-169, 2000.
135. Weinstock M, Kirschenbaum-Slager N, Lazarovici P, Bejar C, Youdim MBH, Shoham S. Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs. Ann NY Acad Sci 939: 148-161, 2001.
136. Youdim MBH, Wadia A, Tatton W, Weinstock M. The anti-Parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivo. Ann NY Acad Sci 939: 450-458, 2001.
137. Weinstock M. Effects of maternal stress on development and behaviour in rat offspring. (invited review) Stress 4: 157-167, 2001.
138. Weinstock M. Alterations induced by gestational stress in brain morphology and behaviour of the offspring. (invited review) Prog Neurobiol 65: 427-451, 2001.
139. Wang RH, Schorer-Apelbaum D, Weinstock M. Testosterone mediates sex difference in hypothermia and cholinesterase inhibition by rivastigmine. Eur J Pharmacol 433: 73-79, 2001.
140. Wang RH, Weinstock M. Steroid hormones mediate sex differences in brain levels of tacrine and its hypothermic effect in the rat. Neuropharmacol 41: 887-894, 2001.
141. Youdim MBH, Weinstock M. Molecular basis of neuroprotective activities of rasagline and the anti-Alzheimer drug, TV3326, [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate] (invited review) Cell Mol Neurobiol 21: 555-573, 2001.
142. Weinstock M, Poltyrev T, Bejar C, Youdim MBH. Effect of TV3326, a novel monoamine-oxidase-cholinesterase inhibitor, in rat models of anxiety and depression. Psychopharmacol 160: 318-324, 2002.
143. Weinstock M. Can the behavioral abnormalities induced by gestational stress in rats be prevented or reversed? (invited review) Stress 5: 167-176, 2002.
144. Youdim MBH, Weinstock M. Novel neuroprotective anti-Alzheimer’s drugs with anti-depressant activity derived from the anti-Parkinson drug, rasagiline. Mech Aging Develop 123: 1081-1086, 2002.
145. Weinstock M, Gorodetsky E, Wang RH, Gross A, Weinreb O, Youdim MBH. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits. Neuropharmacol 43: 999-1005, 2002.
146. Sterling J, Herzig Y, Goren T, Finkelstein N, Lerner D, Goldenberg W, Miskolczi I, Molnar S, Rantal F, Tamas T, Toth G, Zagyva A, Zekany A, Lavian G, Gross A, Friedman R, Razin M, Huang W, Krais B, Chorev M, Youdim MBH, Weinstock M. Novel dual inhibitors of AChE and MAO derived from hydroxyaminoindan and phenethylamine as potential treatment for Alzheimer's disease. J Med Chem 45: 5260-5279, 2002.
147. Yogev-Falach M, Amit T, Bar-Am O, Weinstock M, Youdim MBH. The involvement of mitogen-activated protein (MAP) kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline. FASEB 16: 1674-1676, 2002.
148. Weinstock M, Gorodetsky E, Poltyrev T, Gross A, Sagi Y, Youdim MBH. A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia co-morbid with depression and Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry 27: 555-561, 2003.
149. Maruyama W, Weinstock M, Youdim MBH, Nagai M, Naoi M. Anti-apoptotic action of the anti-Alzheimer drug, TV3326 [(N-propargyl)-(3R) –aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor. Neurosci Letts 341: 233-236, 2003.
150. Sagi Y, Weinstock M, Youdim MBH. Attenuation of MPTP- induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor. J Neurochem 86: 290-297, 2003.
151. Shoham S, Bejar C, Kovalev E, Weinstock M. Intra-cerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp Neurol 184: 1043-1052, 2003.
152. Youdim MBH, Amit T, Bar-Am O, Weinstock M, Yogev-Falach M. Amyloid processing and signal transduction properties of antiParkinson-antiAlzheimer neuroprotective drugs rasagiline and TV3326. Ann NY Acad Sci 993: 378-386, 2003.
153. Drigues N, Poltyrev T, Bejar C, Weinstock M, Youdim MBH. cDNA gene expression profile of rat hippocampus after chronic treatment with antidepressant drugs. J Neural Transm 110: 1413-1436, 2003.
154. Poltyrev T, Weinstock M. Gender difference in the prevention of hyperanxiety in adult prenatally-stressed rats by chronic treatment with amitriptyline. Psychopharmacol 171: 270-276, 2004.
155. Weinstock M, Shoham S. Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity. J Neural Transm 111: 347-366, 2004.
156. Youdim MBH, Weinstock M. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation. Neuro Toxicol 25: 243-250, 2004.
157. Lerman L, Weinstock M, Nudelman A. An improved synthesis of hydroxyindoles. Synthesis 18: 3043-3046, 2004.
158. Beilin B, Bessler H, Papismedov L, Weinstock M, Shavit Y. Continuous physostigmine combined with morphine-based patient-controlled analgesia in the postoperative period. Acta Anaesthesiol Scand 49: 78-84, 2005.
159. Weinstock M. The potential influence of maternal stress hormones on development and mental health of the offspring. (invited review) Brain Behav Immunity 19: 296-308, 2005.
160. Poltyrev T, Gorodetsky E, Bejar C, Schorer-Apelbaum D, Weinstock M. Effect of chronic treatment with ladostigil (TV-3326) on anxiogenic and depressive-like behaviour and on activity of the hypothalamic–pituitary–adrenal axis in male and female prenatally stressed rats. Psychopharmacol 181: 118-125, 2005.
161. Weinstock M, Luques L, Bejar C, Shoham S. Ladostigil, a novel multifunctional drug for the treatment of dementia co-morbid with depression. J Neural Transm [Suppl] 70: 443-447, 2006.
162. Zagron G, Weinstock M. Maternal adrenal hormone secretion mediates behavioural alterations induced by prenatal stress in male and female rats. Behav Brain Res 175: 323-328, 2006.
163. Murmu MS, Salomon S, Biala Y, Weinstock M, Braun K, Bock J. Changes of spine density and dendritic complexity in the prefrontal cortex in offspring of mothers exposed to stress during pregnancy. Eur J Neurosci 24: 1477-1487, 2006.
164. Shoham S, Bejar C, Kovalev E, Schorer-Apelbaum D, Weinstock M. Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats. Neuropharmacol 52: 836-843, 2007.
165. Bogoch Y, Nachum-Biala Y, Linial M, Weinstock M. Anxiety induced by prenatal stress is associated with suppression of hippocampal genes involved in synaptic function. J Neurochem 101: 1018-1030, 2007.
166. Yaka R, Salomon S, Matzner H, Weinstock M. Effect of varied gestational stress on acquisition of spatial memory, hippocampal LTP and synaptic proteins in juvenile male rats. Behav Brain Res 179: 126-132, 2007.
167. Groner E, Ashani Y, Schorer-Apelbaum D, Sterling J, Herzig Y, Weinstock M. The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates. Mol Pharmacol 71: 1610-1617, 2007.
168. Weinstock M. Gender differences in the effects of prenatal stress on brain development and behaviour. Neurochem Res 32: 1730-1740, 2007.
169. Luques L, Shoham S, Weinstock M. Chronic brain cytochrome oxidase inhibition impairs hippocampal cholinergic innervation and memory that is prevented by ladostigil. Exp Neurol 206: 209-219, 2007.
170. Weinstock M. The long-term consequences of prenatal stress. Neurosci Biobehav Rev 32: 1073-1086, 2008.
171. Weinstock M, Groner E. Rational design of a drug for Alzheimer's disease with cholinesterase inhibitory and neuroprotective activity. Chemico-Biological Interactions 175: 216–221, 2008.
172. Nizri E, Irony-Tur-Sinai M, Faranesh N, Lavon I, Lavi E, Weinstock M, Brenner T. Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine. J Neuroimmunol 203: 12-22, 2008.
173. Weinstock M. Intrauterine factors as determinants of depressive disorder (invited review). Isr J Psychiatr Relat Sci 47: 36-45, 2010.
174. Biala YN, Bogoch Y, Bejar C, Linial M, Weinstock M. Prenatal stress diminishes gender differences in behavior and in expression of hippocampal synaptic genes and proteins in rats. Hippocampus 21, 1114-25, 2011.
175. Weinstock M, Luques L, Poltyrev T, Bejar C, Shoham S. Ladostigil prevents age-related glial activation and spatial memory deficits in rats. Neurobiol Aging 32: 1069-1078, 2011.
176. Salomon S, Bejar C, Schorer-Apelbaum D, Weinstock M. Corticosterone mediates some but not other behavioural changes induced by prenatal stress in rats. J Neuroendocrinol 23:118-128, 2011.
177. Zohar I, Weinstock M. Differential effect of prenatal stress on the expression of cortiocotropin-releasing hormone and its receptors in the hypothalamus and amygdala in male and female rats. J Neuroendocrinol 23: 320-328, 2011.
178. Weinstock M. Sex-dependent changes induced by prenatal stress in cortical and hippocampal morphology and behavior in rats: an update. Stress 14: 604-613, 2011.
179. Bock J, Murmu MS, Biala Y, Weinstock M, Braun K. Prenatal stress and neonatal handling induce sex-specific changes in dendritic complexity and dendritic spine density in hippocampal subregions of prepubertal rats. Neuroscience 193: 34-43, 2011.
180. Panarsky R, Luques L, Weinstock M. Anti-inflammatory effects of ladostigil and its metabolites in aged rat brain and in microglial cells. J Neuroimmune Pharmacology 7: 488-498, 2012.
181. Yanovsky I, Finkin-Groner E, Zaikin A, Lerman L, Shalom H, Zeeli S, Weill T, Ginsburg I, Nudelman A, Weinstock M. Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer’s Disease. J Med Chem 55: 10700−10715, 2012.
182. Weinstock M, Bejar C, Schorer-Apelbaum D, Panarsky R, Luques L, Shoham S. Dose-dependent effects of ladostigil on microglial activation and cognition in aged rats. J Neuroimmune Pharmacology 8: 345-355, 2013.
183. Shifrin H, Nadler-Milbauer M, Shoham S, Weinstock M. Rivastigmine alleviates experimentally induced colitis in mice and rats by acting at central and peripheral sites to modulate immune responses. PLoS ONE 8: e57668, 2013.
184. Furman S, Nissim-Bardugo E, Zeeli S, Weitman M, Nudelman A, Finkin-Groner E, Moradov D, Shifrin H, Schorer-Apelbaum D, Weinstock M. Synthesis and in vitro evaluation of anti-inflammatory activity of ester and amine derivatives of indoline in RAW 264.7 and peritoneal macrophages. Bioorganic & Medicinal Chemistry Letters 24: 2283–2287, 2014.
185. Goelman G, Ilinca R, Zohar I, Weinstock M. Functional connectivity in prenatally stressed rats with and without maternal treatment with ladostigil, a brain-selective monoamine oxidase inhibitor, Eur J Neurosci 40: 2734–2743, 2014.
186. Finkin-Groner E, Moradov D, Shifrin H, Bejar C, Nudelman A, Weinstock M. Indoline-3-propionate and 3-aminopropyl carbamates reduce lung injury and pro-inflammatory cytokines induced in mice by LPS. Br J Pharmacol 172: 1101-1113, 2015.
187. Zohar I, Dosoretz-Abittan L, Shoham S, Weinstock M. Sex dependent reduction by prenatal stress of the expression of 5HT1A receptors in the prefrontal cortex and CRF type 2 receptors in the raphe nucleus in rats: reversal by citalopram. Psychopharmacology 232: 1643-1653, 2015.
188. Moradov D, Shifrin H, Harel E, Nadler-Milbauer M, Weinstock M, Srebnik M, Rubinstein A. The antiinflammatory activity of a novel fused-cyclopentenone phosphonate and its potential in the local treatment of experimental colitis. Gastroenterol Res Pract 2015: Article ID 939483, 2015.
189. Moradov D, Finkin-Groner E, Bejar C, Sunita P, Schorer-Apelbaum D, Barasch D, Nemirovski A, Cohen M, Weinstock M. Dose-limiting inhibition of acetylcholinesterase by ladostigil results from the rapid formation and fast hydrolysis of the drug-enzyme complex formed by its major metabolite, R-MCPAI. Biochem Pharmacol 94:164-172, 2015.
190. Weinstock M. Changes induced by prenatal stress in behavior and brain morphology: can they be prevented or reversed? Adv Neurobiol 10: 3-25, 2015.
191. Zohar I, Shoham S, Weinstock M. Perinatal citalopram does not prevent the effect of prenatal stress on anxiety, depressive-like behaviour and serotonergic transmission in adult rat offspring. Eur J Neurosci 43: 590-600, 2016.
192. Barbie-Shoshani, Y, Shoham S, Bejar C, Weinstock M. Sex-Specific Effects of Prenatal Stress on Memory and Markers of Neuronal Activity in Juvenile Rats. Dev Neurosci 38: 206-219, 2016.
193. Weinstock M. Prenatal stressors in rodents: Effects on behavior. Neurobiol Stress 6: 3-13, 2016.
194. Shifrin H, Moradov D, Bejar C, Schorer-Apelbaum D, Weinstock M. Novel indoline derivatives prevent inflammation and ulceration in dinitro-benzene sulfonic acid-induced colitis in rats. Pharmacological Reports 68: 1312-1318, 2016.
195. Weinstock M. Prenatal stressors in rodents: Effects on behavior. Neurobiol Stress 6: 3-13, 2017.
196. Shifrin H, Mouhadeb O, Gluck N, Varol C, Weinstock M. Cholinergic anti-inflammatory pathway does not contribute to prevention of ulcerative colitis by novel indoline carbamates J Neuroimmune Pharmacol 12: 484-491, 2017.
197. Finkin-Groner E, Finkin S, Zeeli S, Weinstock M. Indoline derivatives mitigate liver damage in a mouse model of acute liver injury. Pharmacological Reports 69: 894-902, 2017.
198. Zeeli S, Weill T, Finkin-Groner E, Bejar C, Melamed M, Furman S, Zhenin M, Nudelman A, Weinstock M. Synthesis and Biological Evaluation of Derivatives of Indoline as Highly Potent Antioxidant and Antiinflammatory Agents. J Med Chem 61: 4004-4019, 2018.
199. Shoham S, Linial M, Weinstock M. Age-induced spatial memory deficits in rats are correlated with specific brain region alterations in microglial morphology and gene expression. J Neuroimmune Pharmacology, 14: 251-262, 2019.
200. Dan R, Canetti L, Keadan T, Segman R, Weinstock M, Bonne O, Reuveni I, Goelman G. Sex differences during emotion processing are dependent on the menstrual cycle phase. Psychoneuroendocrinology 100:85–95, 2019.
201. Schneider LS, Geffen Y, Rabinowitz J, Thomas RG, Schmidt R, Ropele S, Weinstock M. Low-dose ladostigil for mild cognitive impairment: a phase 2 placebo-controlled clinical trial Neurology. Oct 8; 93(15):e1474-e1484 2019.
202. Permyakova A, Gammal A, Hinden L, Weitman M, Weinstock M, Tam J. A novel indoline derivative ameliorates diabesity-induced chronic kidney disease by reducing metabolic abnormalities. Front Endocrinol 11:91. doi: 10.3389/ fendo. 2020.00091. 2020 eCollection PMID: 32218769, 2020.
203. Dan R, Reuveni I, Canetti L, Weinstock M, Segman S, Goelman G, Bonne O. Trait-related changes in brain network topology in premenstrual dysphoric disorder. Horm Behav. 124: 104782, 2020.
204. Linial M, Stern A, Weinstock M. Effect of ladostigil treatment of aging rats on gene expression in four brain areas associated with regulation of memory. Neuropharmacology 177: 108229, 2020.
205. Weitman M, Bejar C, Melamed M, Weill T, Yanovsky I, Zeeli S, Nudelman A, Weinstock M. Comparison of the tissue distribution and metabolism of AN1284, a potent anti‑inflammatory agent, after subcutaneous and oral administration in mice. NSAP 394:2077–2089, 2021.
206. Zohar K, Lezmi E, Reichert F, Eliyahu T, Rotshenker S, Weinstock M, Linial M. Profiles and dynamics of the transcriptome of microglial cells reveal their inflammatory status. bioRxiv doi.org/10.1101/2021.12.20.473548.
207. Dan R, Weinstock M, Goelman G. Emotional states as distinct configurations of functional brain networks. Cerebral Cortex, 1-13, 2022. doi.org/10.1093/ cercor/ bhac455.
208. Zohar K, Lezmi E, Reichert F, Eliyahu T, Rotshenker S, Weinstock M, et al. Coordinated Transcriptional Waves Define the Inflammatory Response of Primary Microglial Culture. International Journal of Molecular Sciences [Internet]. 2023;24(13).
209.Yehezkel AS, Abudi N, Nevo Y, Benyamini H, Elgavish S, Weinstock M, et al. AN1284 attenuates steatosis, lipogenesis, and fibrosis in mice with pre-existing non-alcoholic steatohepatitis and directly affects aryl hydrocarbon receptor in a hepatic cell line. Frontiers in Endocrinology [Internet]. 2023;14.
Chapters in books
1. Weinstock M. Action of narcotic drugs in peripheral tissues. In: Narcotic Drugs: Biochemical Pharmacology. Ed. D.H. Clouet. Plenum Press, New York, pp. 394-407, 1971.
2. Weinstock M. Acetylcholine and anticholinesterases In: Narcotic Drugs: Biochemical Pharmacology. Ed. D.H. Clouet. Plenum Press, New York, pp.254-261, 1971.
3. Weinstock M, Speiser Z, Ashkenazi R. Biochemical and pharmacological studies on an animal model of hyperactivity states. In: The impact of Biology on Modern Psychiatry. Eds. M. Rosenbaum, E. Gershon, R. Belmaker, and S. Kety. Plenum Press, New York, pp. 149-162, 1977.
4. Ashkenazi R, Weinstock M, Speiser Z. The role of catecholamines in hyperactivity induced by social isolation in rats. In: IV Catecholamine Symposium. Eds. E. Usdin and I.J. Kopin. Oxford, Pergamon Press, 1979.
5. Weinstock M. Behavioural effects of -adrenoceptor antagonists associated with blockade of central serotoninergic systems. In: Enzymes and Neurotransmitters in Mental Disease. Eds. E. Usdin, T. Sourkes and M.B.H. Youdim. John Wiley, pp. 431-443, 1980.
6. Schorer-Apelbaum D, Weinstock M, Ben-Ishay D. Increased baroreceptor reflex sensitivity in hypertension-resistant Sabra rats. In: Hypertensive Mechanisms. The spontaneously hypertensive rat as a model to study human hypertension. Eds. Aascher, Clough and Ganten. New York, Schattauer Verlag. Stuttgart, pp. 371-374, 1982.
7. Dalith M, Chorev M, Weinstock M. Prevention of morphine tolerance and cholinergic hypersensitivity by acetylcholinesterase inhibition. In: Muscarinic Cholinergic Mechanisms. Eds. S. Cohen and M. Sokolovsky. Tel Aviv, Freund Publishing House, 1987.
8. Weinstock M, Kay G, Razin M, Enz A. Selective inhibition of acetylcholinesterase and acetylcholine turnover in the cortex and hippocampus. In: Muscarinic Cholinergic Mechanisms. Eds. S. Cohen and M. Sokolovsky. Freund Publishing House, pp. 362-366, 1987.
9. Weinstock M, Golomb E, Weksler-Zangen S, Kaczmarczyk G. Genetic impairment in baroreflex sensitivity and abnormal renin modulation predisposes to salt sensitive hypertension in rabbits. In: Preventive Cardiology: Diagnostic and Metabolic Aspects of Cardiovascular Research, Eds. W. Delius, P. Lippert & H. Wieland. Munich, Urban and Schwarzenberg, pp. 115-127, 1990.
10. Kaczmarczyk G, Koch L,Vogel T, Weinstock M. Sodium intake, baroreflex sensitivity and blood pressure in normal dogs. In: Preventive Cardiology: Diagnostic and Metabolic Aspects of Cardiovascular Research. Eds. W. Delius, P. Lippert & H. Wieland. Munich, Urban and Schwarzenberg, pp. 129-139, 1990.
11. Weinstock M, Razin M, Ringel I, Tashma Z, Chorev M. Acetylcholinesterase inhibiton by novel carbamates: A kinetic and nuclear magnetic resonance study. In: Multidisciplinary Approaches to Cholinesterase Functions. Eds. A. Shafferman & B. Velan. New York, Plenum Press, pp. 251-251, 1992.
12. Weinstock M. Gender differences in rats sympathoadrenal activity at rest and in response to stress. In: Stress: Neural Endocrine and Molecular Studies. Eds. R. McCarty, G. Aguilera, E. Sabban, & R. Kvetnansky. Lausanne Switzerland, OPA publishers, 1992.
13. Weinstock M. Neurogenic hypertension. In: Handbook of Hypertension. 4: Ed. D. Ganten. The Netherlands, Elsevier, 1994.
14. Kay G, Malool R, Poltyrev T, Tarcic N, Weinstock M. Effect of gestational stress on immune function of offspring at rest and after exposure to novelty. In: Stress: Molecular Genetic and Neurobiological Advances. Eds. R. McCarty, G. Aguilera, E. Sabban, & R. Kvetnansky. New York, Gordon and Breach, pp. 771-776, 1996.
15. Weinstock M, Poltyrev T, Keshet GI, Malool R. Effect of naloxone on behavior and activation of hypothalamic-pituitary adrenal axis in prenatally-stressed rats exposed to novel environments. In: Stress: Molecular Genetic and Neurobiological Advances. Eds. R. McCarty, G. Aguilera, E. Sabban, & R. Kvetnansky. New York, Gordon and Breach, pp. 935-948, 1996.
16. Weinstock M. Long-term effects of gestational stress on behaviour and pituitary- adrenal function. In: New Frontiers in Stress Research, Modulation of Brain Function. [Introduction to the Biology of Stress] Eds. A. Levy, E. Grauer, D. Ben Nathan, E.R. de Kloet, Chur, Switzerland, Harwood Academic, pp. 155-161, 1998.
17. Weinstock M. Behavioral and neurohormonal sequelae of prenatal stress: a suggested model of depression. In: Contemporary Issues in Modeling Psychopathology, Eds. M. Myslobodsky, I. Weiner. Kluwer Academic Publishers, Massachusetts, pp. 45-54, 2000.
18. Weinstock M, Poltyrev T, Bejar C, Sagi Y, Youdim MBH. TV3326, a novel cholinesterase and MAO inhibitor for Alzheimer's disease with co-morbidity of Parkinson's disease and depression. In: Mapping the progress of Alzheimer’s and Parkinson’s disease. Eds. Y. Mizuno, A. Fisher, I. Hanin. Kluwer Academic/ Plenum Publishers, New York, pp. 199-204, 2002.
19. Weinstock M, Billig H. Drugs in the elderly. In: Old Age and Aging in Israel and the World. Ed. A.J. Rosin, JDC-Eshel (Hebrew), Israel pp. 877-893, 2003.
20. Weinstock M, Wang RH. Sex differences in the actions of cholinesterase inhibitors. In: Cholinergic Mechanisms: Function and Dysfunction. Eds. I. Silman, H. Soreq, L. Anglister, D. Michaelson, A. Fisher, Taylor & Francis, London & New York, pp. 271-275, 2004.
21. Weinstock M. Convergence of antidementia and antidepressant pharmacology. In: Cognition and Mood Interactions, ed. M-K Sun, New York, Nova Science Publisher, Inc., pp.185-225, 2005.
22. Weinstock M. The role of prenatal stress in the programming of behaviour. In: Perinatal Programming: Early Life Determinants of Adult Health and Disease, eds. D.M. Hodgson C.L. Coe, Taylor and Francis, UK, pp. 241-253, 2006.
23. Bier AI, Bogoch Y, Linial M, Weinstock M. Differential gene expression and memory deficit in young and middle-aged rats induced by bilateral carotid occlusion. In: New Trends in Alzheimer and Parkinson Related Disorders: ADPD 2007. Medimond International Proceedings, Italy, pp. 19-23, 2007.
24. Weinstock M, Luques L, Shoham S. Memory deficit induced by chronic inhibition of cytochrome oxidase in rats results from alteration in hippocampal cholinergic transmission. In: New Trends in Alzheimer and Parkinson Related Disorders: ADPD 2007. Medimond International Proceedings, Italy, pp. 95-97, 2007.
25. Weinstock M. Contribution of early life stress to anxiety disorder. In: Stress: from molecules to behaviour, eds. Hermona Soreq, Alon Friedman and Daniela Kaufer, Wiley-Blackwell, pp189-208 (chapter 10), 2010.
26. Weinstock M. Changes induced by prenatal stress in behavior and brain morphology. Can they be prevented or reversed? In: Perinatal Programming of Neurodevelopment. Ed. Marta Antonelli, Springer; Adv Neurobiol 10: 3-25, 2015.
27. Weinstock M. Linking citalopram, serotonin reuptake inhibitors, and depressed pregnant women. In: The Neuroscience of Depression Features, Diagnosis, and Treatment Eds Colin R. Martin, Lan-Anh Hunter Vinood B. Patel Victor R. Preedy Rajkumar Rajendram, Elseiver Academic Press 325-337, 2021.
